Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1
Review
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,882 | Dovepress* | 6,882+ | 2,721 | 9,603 | |
Totals | 6,882 | 2,721 | 9,603 | ||
*Since 8 February 2008 +Since July 2016 |
View citations on Google Scholar